bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories.
bioMérieux Fundamentals Summary
How do bioMérieux's earnings and revenue compare to its market cap?
How experienced are the management team and are they aligned to shareholders interests?
4.2yrs
Average management tenure
CEO
Alexandre Merieux (47 yo)
4.42yrs
Tenure
€1,486,894
Compensation
Mr. Alexandre Merieux serves as the Chairman and Chief Executive Officer of bioMérieux, Inc. Mr. Merieux serves as the President and Chairman of the Management Board of Merieux Développement SAS. He joined...
CEO Compensation Analysis
Compensation vs Market: Alexandre's total compensation ($USD1.55M) is below average for companies of similar size in the French market ($USD3.61M).
Compensation vs Earnings: Alexandre's compensation has increased by more than 20% in the past year.
Leadership Team
Experienced Management: BIM's management team is considered experienced (4.2 years average tenure).
Board Members
Experienced Board: BIM's board of directors are considered experienced (9 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
bioMérieux S.A.'s employee growth, exchange listings and data sources
All financial data provided by Standard & Poor's Capital IQ.
Data
Last Updated (UTC time)
Company Analysis
2022/05/15 00:00
End of Day Share Price
2022/05/13 00:00
Earnings
2021/12/31
Annual Earnings
2021/12/31
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.